Topical Diclofenac Clears AK Lesions

Article

San Francisco - Diclofenac sodium 3 percent in hyaluronan 2.5 percent gel (Solaraze Gel) offers a useful alternative for topical treatment of actinic keratoses (AKs) in patients with multiple lesions, John E. Wolf Jr., M.D., said at the annual meeting of the American Academy of Dermatology.

Related Videos
Related Content

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023

Get Ready to Test Your Atopic Dermatitis Knowledge

October 2nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

FDA Issues Complete Response Letter for Lebrikizumab

October 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall

October 2nd 2023

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023
© 2023 MJH Life Sciences

All rights reserved.